New medical devices and products are often placed on the market with a limited understanding of their risks and benefits; therefore, manufacturers, regulators, payors, users, and patients rely on a robust post-market surveillance (PMS) system.
While PMS has traditionally been a passive activity—often limited to managing complaints and submitting incident reports—reporting alone cannot capture all the risks related to the safe and effective use of medical devices.
Fill in the form and click Watch Now > > >
In this webinar, we discussed how PMS can go from a passive to a proactive process, including:
- Changes in global PMS requirements
- Qualities of a modern PMS system
- How to obtain better clinical and safety data
- Standards that underlie global QMS requirements
About the Presenter
Jay Crowley, Vice President of Medical Device Solutions and Services